menu
    • menu

    Company profile for ISU ABXIS

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ISU ABXIS is constantly endeavoring to become a company that can improve the quality of lives of patients with incurable diseases such as cancer and rare diseases by providing valuable treatment methods based on the biotechnology, provide opportunity for self-realization to employees, and contribute to the society by fulfilling social responsibilities and ethical management.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ISU ABXISkorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    5th fl. Global R&D Center Building C, 22 Daewangpangyoro 712-beongil, Bundang-...
    Telephone
    Telephone
    +82-31-696-4700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.abxis.com/eng/index.jsp
    Linkedin
    Linkedin
    https://www.linkedin.com/company/isu-abxis-co.-ltd
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eucure Announces Partnership with ISU ABXIS for Tri-specific Antibodies
    Eucure Announces Partnership with ISU ABXIS for Tri-specific Antibodies

    31 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221031005342/en

    BUSINESSWIRE
    31 Oct 2022
    Share Share
    Euho & ISU ABXIS to develop trispecific antibodies based on YH003 sequence
    Euho & ISU ABXIS to develop trispecific antibodies based on YH003 sequence

    31 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221031005342/en/Eucure-Biopharma-a-Subsidiary-of-Biocytogen-Announces-Partnership-with-ISU-ABXIS-for-the-Development-of-Tri-specific-Antibodies-using-YH003-Antibody-Sequence

    BUSINESSWIRE
    31 Oct 2022
    Share Share
    Isu Abxis “expects 100% exclusive treatment for Gaucher disease in Algeria”
    Isu Abxis “expects 100% exclusive treatment for Gaucher disease in Algeria”

    12 Oct 2022

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/isu-abxis-ranked-first-for-two-consecutive-years-in-the-algerian-gaucher-disease-treatment-bidding-35378.pdf

    PRESS RELEASE
    12 Oct 2022
    Share Share
    Isu Abxis, ranked first for two consecutive years in the Algerian Gaucher disease treatment bidding
    Isu Abxis, ranked first for two consecutive years in the Algerian Gaucher disease treatment bidding

    26 Aug 2022

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/isu-abxis-ranked-first-for-two-consecutive-years-in-the-algerian-gaucher-disease-treatment-bidding-79217.pdf

    PRESS RELEASE
    26 Aug 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search